Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Stent structure
Reexamination Certificate
1999-02-25
2001-08-28
Recla, Henry J. (Department: 3731)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Stent structure
C623S001230
Reexamination Certificate
active
06280467
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to the area of blood vessel graft systems. More particularly, the present invention provides a catheter base delivery device for deployment of multi-stage stented grafts comprising multiple coaxial delivery mechanisms. The coaxial delivery device enables the multiple stages of a stented graft to be assembled endovascularly.
2. Description of the Related Art
Aortic aneurysms are a common type of deteriorating disease caused by weakening of the wall of a blood vessel. The weakened wall, under the pressure of flowing blood, balloons outward. Such a deformity in the wall of a blood vessel not only affects its ability to conduct blood but is also potentially fatal if a rupture occurs at the site of the aneurysm.
Traditionally, the treatment for aneurysms entailed removing part or all of the aneurysm and implanting a replacement prosthetic section into the lumen. Alternatively, a synthetic or biomaterial graft is sutured end-to-end completely replacing the excised portion of the blood vessel. However, surgical treatment or removal of the aneurysm involves significant invasive techniques, extended hospitalization and associated risk of complications. Complications include extensive blood loss, respiratory tract infections, wound infections, and renal failure. In addition, the mortality rates (8%) are significant for such surgeries.
A more contemporary method of treatment of aneurysms is to place a graft within the lumen of the weakened blood vessel via a catheter based device. Conventional tubular aortic replacement sections, however, are generally larger in diameter than the femoral artery and therefore can not be inserted through the lumen of the femoral artery. The basic concept of a transluminal placement of an endovascular prosthesis for decreasing risk associated with the surgical repair of aortic aneurysms was proposed by Dotter (1969
, Invest Radiol
. 4:329-332). Since then, several investigators have studies the feasibility of different endovascular devices. For example Lazarus (U.S. Pat. No. 5,669,936) discloses a graft system having a capsule catheter that is deployed after femoral arteriotomy. To date, stent-grafts used clinically for treatment of abdominal and thoracic aortic aneurysms have required 18-F to 30-F delivery systems. The large size of the delivery system necessitated surgical femoral arteriotomy and sometimes retroperitoneal left iliac arteriotomy or distal aorta aortotomy, general anesthesia, and high levels of multidisciplinary cooperation. Occasionally, relatively healthy iliac vessels with large diameters are needed or in patients with highly sclerotic tortuous iliac arteries, angioplasty with or without stenting was necessary for performance of endovascular grafting. None of the clinically used devices is suitable for percutaneous insertion; all require a femoral arteriotomy because of their size.
Recently, a catheter based system for the delivery of grafts for repair of aortic aneurysms was disclosed in U.S. Pat. Nos. 5,713,917 and 5,591,195. The system includes a single stage graft comprised of two Nitinol springs. The two Nitinol springs are in physical communication with each other via a Nitinol connecting bar and are embedded in graft material at each end and covered completely by material so as to prevent direct exposure to bodily fluids or tissues. The graft is deployed by using an elongated sheath introducer having an axially extending sheath passage for receiving the graft and maintaining it in a compressed condition. A flexible push rod around the insertion catheter and within the sheath passage is used to push the graft out of the sheath during deployment.
In theory, one way to decrease the size of an endovascular device is to deploy the stented graft as separate parts. However, none of the delivery devices available are suitable for delivery of a multi-stage stented graft by a single percutaneous insertion. There is thus, an ongoing need for graft delivery devices for treatment of aneurysms which requires minimal preparation and hospitalization.
SUMMARY OF THE INVENTION
The present invention provides a multi-stage stented graft that is easily introduced and implanted by percutaneous insertion for the treatment of aneurysms, and which circumvents the need for suturing or stapling to the wall of the blood vessel. The various stages of the stented graft are assembled endovascularly. Accordingly, it is an object of the invention to provide a multi-stage stented graft for implantation into blood vessels.
Another object of the present invention is to provide a multi-stage stented graft that does not have any barbs or hooks for anchoring to the wall of the blood vessel.
Still another object of the present invention is to provide a delivery device for a multi-stage stented graft that requires a single percutaneous insertion.
Yet another object of the present invention is to provide a method for deployment of a multi-stage stented graft using a multiple coaxial delivery device, wherein the stented graft is assembled endovascularly from the multiple stages.
A still further object of the present invention is that the stented graft serves as a substrate for the growth of cells, lining the lumen of the blood vessels in the area of an aneurysm.
These and other aspects of the present invention will become more apparent to those skilled in the art by reference to the following description and to the appended drawings.
REFERENCES:
patent: 3625745 (1971-12-01), Wright et al.
patent: 4512338 (1985-04-01), Balko et al.
patent: 4580568 (1986-04-01), Gianturco
patent: 4651738 (1987-03-01), Demer et al.
patent: 4665918 (1987-05-01), Garza et al.
patent: 4875480 (1989-10-01), Imbert
patent: 4990151 (1991-02-01), Wallstén
patent: 5035706 (1991-07-01), Giantureo et al.
patent: 5064435 (1991-11-01), Porter
patent: 5092877 (1992-03-01), Pinchuk
patent: 5104399 (1992-04-01), Lazarus
patent: 5158548 (1992-10-01), Lau et al.
patent: 5195058 (1993-03-01), Simon
patent: 5201757 (1993-04-01), Heyn et al.
patent: 5242399 (1993-09-01), Lau et al.
patent: 5275622 (1994-01-01), Lazarus et al.
patent: 5282824 (1994-02-01), Giantureo
patent: 5433723 (1995-07-01), Lindenberg et al.
patent: 5443477 (1995-08-01), Marin et al.
patent: 5458615 (1995-10-01), Klemm et al.
patent: 5480423 (1996-01-01), Ravenscroft et al.
patent: 5484418 (1996-01-01), Quiachon et al.
patent: 5489295 (1996-02-01), Piplani et al.
patent: 5507769 (1996-04-01), Marin et al.
patent: 5549663 (1996-08-01), Cottone, Jr.
patent: 5619891 (1997-04-01), Tiede
patent: 5626608 (1997-05-01), Cuny et al.
patent: 5628783 (1997-05-01), Quiachon et al.
patent: 5662675 (1997-09-01), Stockert et al.
patent: 5683449 (1997-11-01), Marcade
patent: 5713917 (1998-02-01), Leonhardt et al.
patent: 5735873 (1998-04-01), MacLean
patent: 0 472 731 A1 (1991-02-01), None
patent: 0 505 686 A1 (1992-09-01), None
patent: 0 508 473 A2 (1992-10-01), None
patent: 0 518 839 A2 (1992-12-01), None
patent: 0 539 237 A1 (1993-04-01), None
patent: 0 732 089 A2 (1996-09-01), None
Bui Vy Q.
Recla Henry J.
Sterne, Kessler, Goldst & Fox P.L.L.C.
World Medical Manufacturing Corporation
LandOfFree
Delivery system for deployment and endovascular assembly of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delivery system for deployment and endovascular assembly of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delivery system for deployment and endovascular assembly of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2540364